NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and ...

Law Offices of Frank R. Cruz Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors To Inquire About Securities ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (“Maravai ...

Fintel reports that on February 26, 2025, Baird downgraded their outlook for Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on ...

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This represents an ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price hit a new 52-week low on Tuesday after Bank of America lowered their price target on the stock from $9.00 to $8.00.

In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stands against the other cash-rich penny stocks. Shares priced under $5, commonly referred ...

The suit alleges defendants issued false statements concerning Maravai business and prospects, resulting in its stock trading at inflated prices.